Cargando…
Tumor-associated autoantibodies correlate with poor outcome in prostate cancer patients treated with androgen deprivation and external beam radiation therapy
Standard cancer treatments trigger immune responses that may influence tumor control. The nature of these responses varies depending on the tumor and the treatment modality. We previously reported that radiation and androgen-deprivation therapy (ADT) induce tumor-associated autoantibody responses in...
Autores principales: | Johnson, Lisa DS, Nesslinger, Nancy J, Blood, Paul A, Chima, Navraj, Richier, Lindsay R, Ludgate, Charles, Pai, Howard H, Lim, Jan T, Nelson, Brad H, Vlachaki, Maria T, Lum, Julian J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125379/ https://www.ncbi.nlm.nih.gov/pubmed/25114831 http://dx.doi.org/10.4161/onci.29243 |
Ejemplares similares
-
Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003) -
Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer
por: Kinaan, Mustafa, et al.
Publicado: (2020) -
Lacrimal sac adenocarcinoma managed with androgen deprivation
por: Abramson, David H., et al.
Publicado: (2020) -
Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy
por: Kalina, Jennifer L., et al.
Publicado: (2017) -
Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)